News and commentary from the psychiatry world
— News and commentary from the psychiatry world
July 22, 2026
• 2 min read
The use of GLP-1 receptor agonists was associated with a lower risk of alcohol-related hospitalization in adults with alcohol addiction, a retrospective study found. (BMJ Open)
GLP-1 drugs for obesity were linked with reduced binge eating-related behaviors and emotional eating in a systematic review and meta-analysis. (eClinicalMedicine)
News and commentary from the psychiatry world
From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace…
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than…
News and commentary from the endocrinology world
Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once.
News and commentary from the world of gastroenterology and hepatology
